Bryan Giraudo - May 5, 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
COO/CFO
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
May 5, 2023
Transactions value $
$0
Form type
4
Date filed
5/9/2023, 04:15 PM
Previous filing
Apr 5, 2023
Next filing
Jul 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Disposed to Issuer -145K -100% 0 May 5, 2023 Common Stock 145K $22.10 Direct F1, F2
transaction GOSS Stock Option (Right to Buy) Disposed to Issuer -71.5K -100% 0 May 5, 2023 Common Stock 71.5K $14.55 Direct F3, F4
transaction GOSS Stock Option (Right to Buy) Disposed to Issuer -90K -100% 0 May 5, 2023 Common Stock 90K $9.79 Direct F5, F6
transaction GOSS Stock Option (Right to Buy) Disposed to Issuer -150K -100% 0 May 5, 2023 Common Stock 150K $10.54 Direct F7, F8
transaction GOSS Stock Option (Right to Buy) Disposed to Issuer -265K -100% 0 May 5, 2023 Common Stock 265K $11.94 Direct F9, F10
transaction GOSS Stock Option (Right to Buy) Award +96.7K 96.7K May 5, 2023 Common Stock 96.7K $1.36 Direct F1, F2, F11
transaction GOSS Stock Option (Right to Buy) Award +47.7K 47.7K May 5, 2023 Common Stock 47.7K $1.36 Direct F3, F4, F11
transaction GOSS Stock Option (Right to Buy) Award +60K 60K May 5, 2023 Common Stock 60K $1.36 Direct F5, F6, F11
transaction GOSS Stock Option (Right to Buy) Award +100K 100K May 5, 2023 Common Stock 100K $1.36 Direct F7, F8, F11
transaction GOSS Stock Option (Right to Buy) Award +177K 177K May 5, 2023 Common Stock 177K $1.36 Direct F9, F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested.
F2 On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 96,667 options to purchase common stock having a lower exercise price with the same vesting terms.
F3 25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F4 On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms.
F5 25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F6 On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms.
F7 25% of the total number of shares subject to the option vested on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.
F8 On May 5, 2023, the Issuer canceled an option granted on September 16, 2021. In exchange for the canceled option, the reporting person received 100,000 options to purchase common stock having a lower exercise price with the same vesting terms.
F9 One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F10 On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 176,677 options to purchase common stock having a lower exercise price with the same vesting terms.
F11 The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted.